N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease
about
The effect of the NMDA channel blocker memantine on salicylate-induced tinnitus in rats.Self-Organizing Feature Maps Identify Proteins Critical to Learning in a Mouse Model of Down SyndromeWeight Loss in Patients with Dementia: Considering the Potential Impact of Pharmacotherapy.The effect of Sailuotong (SLT) on neurocognitive and cardiovascular function in healthy adults: a randomised, double-blind, placebo controlled crossover pilot trialEvidence that Memantine Reduces Chronic Tinnitus Caused by Acoustic Trauma in Rats.Antipsychotic, antidepressant, and cognitive-impairment properties of antipsychotics: rat profile and implications for behavioral and psychological symptoms of dementia.Different oxysterols have opposing actions at N-methyl-D-aspartate receptors.Inhibition of NR2B-Containing N-methyl-D-Aspartate Receptors (NMDARs) in Experimental Autoimmune Encephalomyelitis, a Model of Multiple SclerosisChiropractic management of a 24-year-old woman with idiopathic, intermittent right-sided hemiparesthesiaA Systematic Review of Intervention Studies Examining Nutritional and Herbal Therapies for Mild Cognitive Impairment and Dementia Using Neuroimaging Methods: Study Characteristics and Intervention Efficacy.A Mutation in DAOA Modifies the Age of Onset in PSEN1 E280A Alzheimer's DiseaseEnhancement of postsynaptic GABAA and extrasynaptic NMDA receptor-mediated responses in the barrel cortex of Mecp2-null mice.Quantification of the novel N-methyl-d-aspartate receptor ligand [11C]GMOM in manPreventive effects of imperatorin on perfluorohexanesulfonate-induced neuronal apoptosis via inhibition of intracellular calcium-mediated ERK pathway.Hydrogen Sulfide Prevents Synaptic Plasticity from VD-Induced Damage via Akt/GSK-3β Pathway and Notch Signaling Pathway in Rats.Effect of Preoperative Oral Amantadine on Acute and Chronic Postoperative Pain After Mandibular Fracture SurgeryProtective effects of carnosine on white matter damage induced by chronic cerebral hypoperfusion.ADN-1184 a monoaminergic ligand with 5-HT(6/7) receptor antagonist activity: pharmacological profile and potential therapeutic utility.The cytotoxic effect of memantine and its effect on cytoskeletal proteins expression in metastatic breast cancer cell line.The smallest stroke: occlusion of one penetrating vessel leads to infarction and a cognitive deficit.Copper-dependent regulation of NMDA receptors by cellular prion protein: implications for neurodegenerative disorders.Combination of Aβ clearance and neurotrophic factors as a potential treatment for Alzheimer's disease.A systematic review of the effects of NMDA receptor antagonists on oscillatory activity recorded in vivo.New strategies to develop novel pain therapies: addressing thermoreceptors from different points of view.Genome-wide association study of language performance in Alzheimer's disease.Relationship between Zinc (Zn (2+) ) and Glutamate Receptors in the Processes Underlying Neurodegeneration.Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia.The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes.Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.Tetramethylpyrazine nitrone protects retinal ganglion cells against N-methyl-d-aspartate-induced excitotoxicity.Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease.Immunosuppression by N-methyl-D-aspartate receptor antagonists is mediated through inhibition of Kv1.3 and KCa3.1 channels in T cells.Effects of Hydrogen Sulfide on Modulation of Theta-Gamma Coupling in Hippocampus in Vascular Dementia Rats.Comparative Neuroprotective Effects of Dietary Curcumin and Solid Lipid Curcumin Particles in Cultured Mouse Neuroblastoma Cells after Exposure to Aβ42Amyloid Beta and tau proteins as therapeutic targets for Alzheimer's disease treatment: rethinking the current strategy.A cell-based functional assay using a green fluorescent protein-based calcium indicator dCys-GCaMP.Memantine for the treatment of general neuropathic pain: a narrative review.Chiropractic management of an 81-year-old man with Parkinson disease signs and symptoms.Characterization of a Synthetic Steroid 24-keto-cholest-5-en-3β, 19-diol as a Neuroprotectant.Ethanol preconditioning of rat cerebellar cultures targets NMDA receptors to the synapse and enhances peroxiredoxin 2 expression.
P2860
Q28386765-9BA5243B-4094-480B-9CD0-E06F7627777AQ28545764-EB8B4C7E-F1AE-4EF7-9AF9-92D312A9A6EFQ30234535-C30A6E8B-4646-43DC-9414-CEE7052DDF4DQ30393704-C6C4059C-3366-4369-A281-F2C024062AA9Q30463382-1D6C9978-0CFE-4CB8-B412-966C9C00A272Q33605869-561EEE12-F924-4F22-8756-FE56D6CC477DQ33934419-66740B83-7A42-43C6-A547-B9F1479D2C64Q34146191-8A1DFAA6-4DB6-46A8-86B4-94F13B99EA03Q35462231-376B740C-1064-427B-977D-F3ABB0643EA0Q36311575-BDDBA906-5940-4455-8D6B-FC6AC47323C4Q36580288-D44BBDF3-3139-4BA3-B509-A17315ADE55EQ36729733-8F0BE9E5-C271-4456-A9A1-6270D3F79E33Q36996488-3F26A6D0-315E-4C2B-8E9B-6C520C6B3619Q37060292-0C0727BB-7C6C-4BCF-8260-2ED03E6692C7Q37075664-860832C3-0028-4CDE-96D6-3077910628A2Q37246134-AAB8E40C-EDAC-48D5-A717-6832EB6E77E5Q37387274-DBCEAA23-CC99-4349-AD79-0EF42E00D1D5Q37585410-055D53EB-D08A-40E5-96B6-02874D2BDE34Q37592867-601CA395-AA8A-49A9-836F-CA1ACCF37F28Q37634991-E56A165C-78D3-47AF-A9FB-7B9F354E9F7CQ37981836-31D391E8-C529-4F13-BC35-D61D2E9D96A8Q38062334-1A4F89EA-E760-475E-9501-61E570E56DE0Q38122300-D35C9334-1D5F-4D37-B563-1BCC39B044A3Q38167283-B94BAFF5-4C1C-4FD8-A0F3-73AECDCC0357Q38376090-B3FD8B0F-3AEA-44EB-8053-A28C72397680Q38536615-DDD823FE-1AC0-459F-AFBB-699AFCC13383Q38661735-51905833-0E40-409D-9F45-2516DB1082D4Q38775856-F524A288-B0AD-4E52-B393-E066A9AA474CQ38962796-4E6A6E8C-A5DB-40FB-A814-00E1D0DA27DBQ38979665-F908D0D2-F54F-4DF3-9C64-2161A7DABE98Q39387480-66D5A6E6-637E-49E4-A005-08A4A02F5AD0Q39685182-EAB6C889-A878-4FCA-B82D-08281A4054C6Q41215744-59D5118F-CE28-4BA5-94FF-7E3A13EBE8A0Q41785626-ACB5A741-B66D-431B-AD33-1C8541635A2FQ42281747-EEFC7693-2D03-43A2-B114-ECBD2395F012Q42837432-A767B087-F10F-47DB-AA58-F2A90ADF0B75Q43061597-F88A6E45-BED4-4297-82C8-E67E01EFA457Q43139547-94344D37-B122-4002-8429-47B6283ACBE0Q43580240-B925DE07-0407-4BFD-A6AA-5347731275B6Q47136365-46FCD3E5-2110-4875-B7A3-4E0A117BABB8
P2860
N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
N-methyl D-aspartate (NMDA) re ...... mentia and Parkinson's disease
@ast
N-methyl D-aspartate (NMDA) re ...... mentia and Parkinson's disease
@en
N-methyl D-aspartate (NMDA) re ...... mentia and Parkinson's disease
@nl
type
label
N-methyl D-aspartate (NMDA) re ...... mentia and Parkinson's disease
@ast
N-methyl D-aspartate (NMDA) re ...... mentia and Parkinson's disease
@en
N-methyl D-aspartate (NMDA) re ...... mentia and Parkinson's disease
@nl
prefLabel
N-methyl D-aspartate (NMDA) re ...... mentia and Parkinson's disease
@ast
N-methyl D-aspartate (NMDA) re ...... mentia and Parkinson's disease
@en
N-methyl D-aspartate (NMDA) re ...... mentia and Parkinson's disease
@nl
P2093
P2860
P921
P3181
P1476
N-methyl D-aspartate (NMDA) re ...... mentia and Parkinson's disease
@en
P2093
David Olivares
Debomoy K Lahiri
Nigel H Greig
Varun K Deshpande
Xudong Huang
P2860
P304
P3181
P356
10.2174/156720512801322564
P407
P577
2012-07-01T00:00:00Z